Bruni, A. https://orcid.org/0000-0003-1068-5958
Ingrosso, G.
Trippa, F.
Di Staso, M.
Lanfranchi, B.
Rubino, L.
Parente, S.
Frassinelli, L.
Maranzano, E.
Santoni, R.
Sighinolfi, M. C.
Lohr, F.
Mazzeo, E.
Article History
Received: 24 January 2019
Accepted: 7 March 2019
First Online: 13 March 2019
Compliance with ethical standards
:
: Alessio Bruni was member of an Advisory Board for Astra Zeneca receiving a Grant. He also received a sponsorship from Ferring, Janssen and Astellas to participate to National and International Conference. He also received a speaker honorarium from Astra Zeneca. Gianluca Ingrosso declares he has no conflict of interests. Fabio Trippa declares he has no conflict of interests, Mario Di Staso declares he has no conflict of interests, Biancaluisa Lanfranchi declares he has no conflict of interests. Laura Rubino declares he has no conflict of interests; Silvia Parente declares he has no conflict of interest. Luca Frassinelli declares he has no conflict of interests. Ernesto Maranzano declares he has no conflict of interests. Riccardo Santoni declares he has no conflict of interests. Maria Chiara Sighinolfi declares he has no conflict of interests. Frank Lohr declares he has no conflict of interests. Ercole Mazzeo received an honorarium as expert from Janssen.
: All procedures performed in the study were in accordance with the ethical standards of the Institutional and National Research Committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent for the treatment proposed was obtained from all individual participants included in the study.